Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elena Castaldi"'
Autor:
Benjamin Guillet, Philippe Garrigue, Pauline Brige, Françoise Dignat-George, Elena Castaldi, Jimmy Stalin, Youssef Bennis, Lionel Velly, Florence Sabatier, Guillaume Hache, Lionel Pellegrini, Francesca Orlandi
Publikováno v:
Journal of Nuclear Medicine
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2016, 57 (11), pp.1798-1804. ⟨10.2967/jnumed.115.170308⟩
Journal of Nuclear Medicine, 2016, 57 (11), pp.1798-1804. ⟨10.2967/jnumed.115.170308⟩
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2016, 57 (11), pp.1798-1804. ⟨10.2967/jnumed.115.170308⟩
Journal of Nuclear Medicine, 2016, 57 (11), pp.1798-1804. ⟨10.2967/jnumed.115.170308⟩
Endothelial colony-forming cells (ECFCs) are promising candidates for cell therapy of ischemic diseases, as less than 10% of patients with an ischemic stroke are eligible for thrombolysis. We previously reported that erythropoietin priming of ECFCs i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47c91f897dd1450e013b4f4c3919cf77
https://hal-amu.archives-ouvertes.fr/hal-01451166
https://hal-amu.archives-ouvertes.fr/hal-01451166
Autor:
Laura Micol Pizzuti, Anna Nardelli, Daniela Capacchione, Giovanni Ortosecco, Giuseppe Cerciello, Eugenio Di Giorgio, Giovanni Storto, Leonardo Pace, Elena Castaldi, Amalia De Renzo
Publikováno v:
British Journal of Haematology. 151:195-197
Complete List of Authors: Storto, Giovanni; IRCCS CROB, Nuclear Medicine Di Giorgio, Eugenio; Instituto di Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche (CNR), Nuclear Medicine De Renzo, Amalia; Universita “Federico II”, Dipartim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fd73527c0ea449b48b2d834b0457a86
https://doi.org/10.1111/j.1365-2141.2010.08335.x
https://doi.org/10.1111/j.1365-2141.2010.08335.x
Autor:
Antonio Speranza, Giovanni Storto, Marco Salvatore, Leonardo Pace, Giovanni Ortosecco, Elena Castaldi, Anna Nardelli
Publikováno v:
Applied radiation and isotopes 69 (2011): 52–55. doi:10.1016/j.apradiso.2010.09.001
info:cnr-pdr/source/autori:Nardelli, A (1); Castaldi, E (1); Ortosecco, G (1); Speranza, A (1); Storto, G (2); Pace, L (3); Salvatore, M (3)./titolo:Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90/doi:10.1016%2Fj.apradiso.2010.09.001/rivista:Applied radiation and isotopes/anno:2011/pagina_da:52/pagina_a:55/intervallo_pagine:52–55/volume:69
info:cnr-pdr/source/autori:Nardelli, A (1); Castaldi, E (1); Ortosecco, G (1); Speranza, A (1); Storto, G (2); Pace, L (3); Salvatore, M (3)./titolo:Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90/doi:10.1016%2Fj.apradiso.2010.09.001/rivista:Applied radiation and isotopes/anno:2011/pagina_da:52/pagina_a:55/intervallo_pagine:52–55/volume:69
Peptide receptor radionuclide therapy (PRRT) has recently expanded due to radiolabelling of DOTA-peptides, such as the somatostatin analogues [DOTA(0), Tyr(3)]octreotate (DOTATATE). The achievement of high specific activities during procedures has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49084f9cf179118e4410768853d25031
http://hdl.handle.net/11386/3023172
http://hdl.handle.net/11386/3023172
Autor:
Marco Salvatore, Antonio Speranza, Anna Nardelli, Elena Castaldi, Giovanni Ortosecco, Leonardo Pace
Publikováno v:
Applied radiation and isotopes 67 (2009): 1664–1669. doi:10.1016/j.apradiso.2009.04.008
info:cnr-pdr/source/autori:Speranza A; Ortosecco G; Castaldi E; Nardelli A; Pace L; Salvatore M/titolo:Fully automated synthesis procedure of 4-[18F]fluorobenzaldehyde by commercial synthesizer: Amino-oxi peptide labelling prosthetic group/doi:10.1016%2Fj.apradiso.2009.04.008/rivista:Applied radiation and isotopes/anno:2009/pagina_da:1664/pagina_a:1669/intervallo_pagine:1664–1669/volume:67
info:cnr-pdr/source/autori:Speranza A; Ortosecco G; Castaldi E; Nardelli A; Pace L; Salvatore M/titolo:Fully automated synthesis procedure of 4-[18F]fluorobenzaldehyde by commercial synthesizer: Amino-oxi peptide labelling prosthetic group/doi:10.1016%2Fj.apradiso.2009.04.008/rivista:Applied radiation and isotopes/anno:2009/pagina_da:1664/pagina_a:1669/intervallo_pagine:1664–1669/volume:67
Automatic synthesis of 4-[18F]fluorobenzaldehyde has been developed by a commercially available TRACERlab(TM) FXF-N synthesis module to be used as prosthetic group for amino-oxy functionalized peptide labelling in clinical routine application. In add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da6f280a6e1920133693a31f6448b66a
https://pubmed.ncbi.nlm.nih.gov/19443231
https://pubmed.ncbi.nlm.nih.gov/19443231